Osstivia SNEDDS
A high bioavailability evolution of Fructus Ligustri Lucidi Extract. Powered by a complex phytochemical matrix of Oleanolic Acid, Ursolic Acid, Salidroside, Nuzhenide, Specnuezhenide, Oleuropein, and Echinacoside, Osstivia uses a Self-Nanoemulsifying Dietary Delivery System (SNEDDS) to massively increase the permeation of these highly lipophilic botanical compounds. This comprehensive formulation is engineered to actively promote bone growth, trigger remodeling, increase bone density, stimulate osteoblast activity, and aggressively inhibit osteoclasts.
The major formulation upgrade is officially complete and the new, improved formulation is out. We have successfully transitioned from a standard FLL ethanolic extract to a powerful Standardized Extract. As verified by our newly released Certificate of Analysis, it contains a strict 20% Oleanolic Acid, the main active compound driving Osstivia's core benefits. This new formulation delivers a significantly higher concentration of total extract per mL compared to the legacy version, making it a much better value and absolutely worth the upgrade.
Fulfillment Note: We are currently processing hundreds of pre-orders and are shipping in big batches every day over these next few weeks to catch up to the most recent orders. Thank you for your patience!
View 20% Oleanolic Acid CoA
Color differences between legacy Osstivia (left), and new Osstivia (right). Expect a huge improvement and increased value for your purchase.
Ossialabs uses a Self-Nanoemulsifying Dietary Delivery System (SNEDDS) that is shown to increase the bioavailability and permeability of active lipophilic botanical compounds. It is shown in literature to also help bypass first-pass metabolism and leads more compound to be usable.
The SNEDDS Advantage
Average supplements cannot bypass first-pass metabolism and end up destroyed during digestion. We are actively advancing the science with what we have, unlike the standard supplement industry. Click the boxes below to expand details.
SNEDDS Permeation Models
FLL Pathway Breakdown
From the Documentation: A deep dive into the specific molecular pathways modulated by Fructus Ligustri Lucidi (FLL) and how Osstivia amplifies these effects.
Osstivia acts as an amplified, highly bioavailable version of FLL. By using a SNEDDS formulation, it bypasses digestion to saturate these critical pathways far more effectively than standard extractions or powders.
The Phytochemical Matrix
Osstivia's raw power is driven by the synergistic presence of these specific bioactive compounds, highly concentrated and delivered via our nano-emulsion system:
Growth Mechanisms & Science
Important: Osstivia is both dose and time-dependent. Consistent application is required to trigger the growth pathways.
Based on preclinical and emerging clinical data:
Clinical Study Data
Beyond Bone: Systemic Health
While Osstivia is engineered for advanced delivery, the highly concentrated Fructus Ligustri Lucidi (FLL) extract offers a massive spectrum of whole-body health benefits heavily documented in scientific literature.
Learn More
Osstivia is a highly specialized, bioavailability enhanced formulation engineered to actively promote bone growth, amplify natural bone remodeling, and provide comprehensive systemic health support. If you are trying to understand the deeper science, cellular mechanisms, and core purpose behind this advanced botanical extract, read our complete overview.
Read the Full BreakdownCare, Usage & Taste Profile
New Measurement Dosing System
We have upgraded from drops to a precise measurement dropper (mL). Start Low: We recommend starting at 0.5 mL and building up to the optimal dose of 1.0 to 2.0 mL daily.
Consistency is Key: Because Osstivia is dose and time-dependent, we highly recommend purchasing a pack of 5-6 bottles (60mL) to maintain a consistent 1-2mL daily protocol. (Note: If you have the budget, 2mL or more is basically optimal (obviously don't overdose like crazy). Some users have recently started testing 3-6mL daily as well).
How long will your bottle last?
| Daily Dose | 30mL Bottle | 60mL Bottle |
|---|---|---|
| 0.5 mL (Low) | 2 Months | 4 Months |
| 1.0 mL | 1 Month | 2 Months |
| 1.5 mL | 20 Days | 40 Days |
| 2.0 mL (Max) | 2 Weeks | 1 Month |
Scientific References
- Chen et al. Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety. Molecules. 2017;22:1469.
- Xu et al. Fructus Ligustri Lucidi ethanol extract inhibits osteoclastogenesis in RAW264.7 cells via the RANKL signaling pathway. Molecular Medicine Reports. 2016;14:4767-4774.
- Kong et al. The potential mechanism of Fructus Ligustri Lucidi promoting osteogenetic differentiation of BMSCs based on network pharmacology, molecular docking and experimental identification. Bioengineered. 2022;13:10640-10653.
- Chen, B., Wei, J., Zhu, R., et al. (2021). Fructus Ligustri Lucidi aqueous extract promotes calcium balance and short-chain fatty acids production in ovariectomized rats. Journal of Ethnopharmacology, 279, 114348.
- Tang XF, Ma ZT, Gao YY, et al. Systemic osteoprotective effects of Epimedii Folium and Ligustri Lucidi Fructus in senile osteoporosis rats by promoting the osteoblastogenesis and osteoclastogenesis based on MLP-ANN model. Chin Med. 2020;15:87.
- Li L, Chen B, Zhu R, et al. Fructus Ligustri Lucidi preserves bone quality through the regulation of gut microbiota diversity, oxidative stress, TMAO and Sirt6 levels in aging mice. Aging (Albany NY). 2019;11(21):9348-9368.
- Chen L, Huang D, Jiang L, et al. A review of botany, phytochemistry, pharmacology, and applications of the herb with the homology of medicine and food: Ligustrum lucidum W.T. Aiton. Front. Pharmacol. 2024;15:1330732.
- A Milk Product Supplemented with a Herbal Extract for the Prevention of Osteoporosis: Justifications and Clinical Trial. Leung et al. Journal of Food and Nutrition Sciences. (2015).
- Kapoor et al. Biomolecular signals in mandibular condylar cartilage: Bioinformatics and evidence-based insights for optimizing functional appliance therapy. Seminars in Orthodontics. 2025.
- Yang and Ren. Factors Involved in Mandibular Condylar Growth: An Overview. Oral Health and Dental Management. 2014;13:1019-1023.
- Yang et al. Mechanoresponsive and lubricating changes of mandibular condylar cartilage associated with mandibular lateral shift and recovery in the growing rat. Clinical Oral Investigations. 2020;24:3547-3557.
- FLL osteoporosis studies summarized in FLL pharmacology and bone-quality literature, including canonical Wnt/beta-catenin signaling.
- Osteoblast-osteoclast communication and OPG/RANKL/cathepsin K pathways reported in FLL bone-remodeling studies.
- PTHrP/Ihh/Sox9 condylar growth axis described in mandibular condylar cartilage growth and MCC development literature.
- Ligustri Lucidi Fructus postmenopausal osteoporosis studies identifying BMP-Smad/Runx2-related mechanisms.
- FLL bone studies reporting Nrf2/HO-1 and ferroptosis-related osteoporosis mechanisms.
- Feng, Wenjing, et al. "Progress of Ursolic Acid on the Regulation of Macrophage: Summary and Prospect." Frontiers in Immunology, vol. 16, 2025.
- Wal, Pranay, et al. "Multifunctional Roles and Phytopharmacological Potential of Ursolic Acid: An Invaluable Natural Nutraceutical Agent." Russian Journal of Bioorganic Chemistry, vol. 51, no. 1, 2025.
© Ossialabs Advanced research-backed formulations.
Statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.